Krzysztof Piotr Piotr Michalak

Prof. Dr. Krzysztof Piotr Piotr Michalak

orcid
Laboratory of Vision Science and Optometry, Faculty oPhysics...

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
Krzysztof Piotr Piotr MichalakKrzysztof Piotr Piotr Michalak
Krzysztof Piotr Piotr Michalak
AMAmelia Zofia Michalak
Amelia Zofia Michalak
Chronic inflammation is an important component of many diseases, including autoimmune diseases, intracellular infections, dysbiosis and degenerative diseases. An important element of this state is the mainly positive feedback between inflammatory cytokines, reactive oxygen species (ROS), nitric oxide (NO), increased intracellular calcium, hypoxia-inducible factor 1-alpha (HIF-1α) stabilisation and mitochondrial oxidative stress, which, under normal conditions, enhance the response against pathogens. Autophagy and the nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated antioxidant response are mainly negatively coupled with the above-mentioned elements to maintain the defence response at a level appropriate to the severity of the infection. The current review is the first attempt to build a multidimensional model of cellular self-regulation of chronic inflammation. It describes the feedbacks involved in the inflammatory response and explains the possible pathways by which inflammation becomes chronic. The multiplicity of positive feedbacks suggests that symptomatic treatment of chronic inflammation should focus on inhibiting multiple positive feedbacks to effectively suppress all dysregulated elements including inflammation, oxidative stress, calcium stress, mito-stress and other metabolic disturbances.

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Krzysztof Piotr Piotr MichalakKrzysztof Piotr Piotr Michalak
Krzysztof Piotr Piotr Michalak
ASAleksandra Sobolewska-Wlodarczyk
Aleksandra Sobolewska-Wlodarczyk
MWMarcin Włodarczyk
Marcin Włodarczyk
JSJustyna Sobolewska
Justyna Sobolewska
PWPiotr Woźniak
Piotr Woźniak
BSBogusław Sobolewski
Bogusław Sobolewski
Long‐term fluoroquinolone‐associated disability (FQAD) after fluoroquinolone (FQ) antibiotic therapy appears in recent years as a significant medical and social problem, because patients suffer for many years after prescribed antimicrobial FQ treatment from tiredness, concentration problems, neuropathies, tendinopathies, and other symptoms. The knowledge about the molecular activity of FQs in the cells remains unclear in many details. The effective treatment of this chronic state remains difficult and not effective. The current paper reviews the pathobiochemical properties of FQs, hints the directions for further research, and reviews the research concerning the proposed treatment of patients. Based on the analysis of literature, the main directions of possible effective treatment of FQAD are proposed: (a) reduction of the oxidative stress, (b) restoring reduced mitochondrion potential ΔΨm, (c) supplementation of uni‐ and bivalent cations that are chelated by FQs and probably ineffectively transported to the cell (caution must be paid to Fe and Cu because they may generate Fenton reaction), (d) stimulating the mitochondrial proliferation, (e) removing FQs permanently accumulated in the cells (if this phenomenon takes place), and (f) regulating the disturbed gene expression and enzyme activity.

25 October 2015 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Krzysztof Piotr Piotr MichalakKrzysztof Piotr Piotr Michalak
Krzysztof Piotr Piotr Michalak
AMAgnieszka Maćkowska-Kędziora
Agnieszka Maćkowska-Kędziora
BSBogusław Sobolewski
Bogusław Sobolewski
PWPiotr Woźniak
Piotr Woźniak
Glutamine (GLN) is commonly known as an important metabolite used for the growth of cancer cells but the effects of its intake in cancer patients are still not clear. However, GLN is the main substrate for DNA and fatty acid synthesis. On the other hand, it reduces the oxidative stress by glutathione synthesis stimulation, stops the process of cancer cachexia, and nourishes the immunological system and the intestine epithelium, as well. The current paper deals with possible positive effects of GLN supplementation and conditions that should be fulfilled to obtain these effects. The analysis of GLN metabolism suggests that the separation of GLN and carbohydrates in the diet can minimize simultaneous supply of ATP (from glucose) and NADPH2(from glutamine) to cancer cells. It should support to a larger extent the organism to fight against the cancer rather than the cancer cells. GLN cannot be considered the effective source of ATP for cancers with the impaired oxidative phosphorylation and pyruvate dehydrogenase inhibition. GLN intake restores decreased levels of glutathione in the case of chemotherapy and radiotherapy; thus, it facilitates regeneration processes of the intestine epithelium and immunological system.

1 May 2014 in Vision Research
Verified
Journal Article
Closed access
APAnna Przekoracka-Krawczyk
Anna Przekoracka-Krawczyk
PNPaweł Nawrot
Paweł Nawrot
MCMonika Czaińska
Monika Czaińska
Krzysztof Piotr Piotr MichalakKrzysztof Piotr Piotr Michalak
Krzysztof Piotr Piotr Michalak

1 February 2020 in Contact Lens and Anterior Eye
Verified
Journal Article
Closed access
KPKatarzyna Przekoracka
Katarzyna Przekoracka
Krzysztof Piotr Piotr MichalakKrzysztof Piotr Piotr Michalak
Krzysztof Piotr Piotr Michalak
JOJan Olszewski
Jan Olszewski
FZFabrizio Zeri
Fabrizio Zeri
AMAndrzej Michalski
Andrzej Michalski
APAnna Przekoracka-Krawczyk
Anna Przekoracka-Krawczyk

17 April 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
Krzysztof Piotr Piotr MichalakKrzysztof Piotr Piotr Michalak
Krzysztof Piotr Piotr Michalak
AMAmelia Zofia Michalak
Amelia Zofia Michalak
ABAlicja Brenk-Krakowska
Alicja Brenk-Krakowska
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been recognized not only for its acute effects but also for its ability to cause LongCOVID Syndrome (LCS), a condition characterized by persistent symptoms affecting multiple organ systems. This review examines the molecular and immunological mechanisms underlying LCS, with a particular focus on autophagy inhibition, chronic inflammation, oxidative, nitrosative and calcium stress, viral persistence and autoimmunology. Potential pathophysiological mechanisms involved in LCS include (1) autoimmune activation, (2) latent viral persistence, where SARS-CoV-2 continues to influence host metabolism, (3) reactivation of latent pathogens such as Epstein-Barr virus (EBV) or cytomegalovirus (CMV), exacerbating immune and metabolic dysregulation, and (4) possible persistent metabolic and inflammatory dysregulation, where the body fails to restore post-infection homeostasis. The manipulation of cellular pathways by SARS-CoV-2 proteins is a critical aspect of the virus’ ability to evade immune clearance and establish long-term dysfunction. Viral proteins such as NSP13, ORF3a and ORF8 have been shown to disrupt autophagy, thereby impairing viral clearance and promoting immune evasion. In addition, mitochondrial dysfunction, dysregulated calcium signaling, oxidative stress, chronic HIF-1α activation and Nrf2 inhibition create a self-sustaining inflammatory feedback loop that contributes to tissue damage and persistent symptoms. Therefore understanding the molecular basis of LCS is critical for the development of effective therapeutic strategies. Targeting autophagy and Nrf2 activation, glycolysis inhibition, and restoration calcium homeostasis may provide novel strategies to mitigate the long-term consequences of SARS-CoV-2 infection. Future research should focus on personalized therapeutic interventions based on the dominant molecular perturbations in individual patients.